Elevated level of plasma homocysteine in patients with slow coronary flow

International Journal of Cardiology

Volumn 102, Issue 3, 2005, Pages 419-423

  Erbay, Ali Riza ^a   Turhan, Hasan ^a   Yasar, Ayse Saatci ^a   Ayaz, Selime ^a   Sahin, Onur ^a   Senen, Kubilay ^a   Sasmaz, Hatice ^a   Yetkin, Ertan ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endothelial dysfunction; Homocysteine; Slow coronary flow

Indexed keywords

HOMOCYSTINE;

ADULT; ANGIOGRAPHY; ARTICLE; BLOOD LEVEL; CALCULATION; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DATA ANALYSIS; DIABETES MELLITUS; EPICARDIUM; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STANDARD; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMIC PROCESSES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; TURKEY;

EID: 84928485346     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.05.064     Document Type: Article

References (32)

1. A.A. Tambe, M.A. Demany, H.A. Zimmerman, and E. Mascarenhas Angina pectoris and slow flow velocity of dye in coronary arteries. A new angiographic finding Am. Heart J. 84 1972 66 71
2. E. Mangieri, G. Macchiarelli, M. Ciavolella, F. Barilla, A. Avella, and A. Martinotti Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries Catheter. Cardiovasc. Diagn. 37 1996 375 381
3. M. Mosseri, R. Yarom, M.S. Gotsman, and Y. Hasin Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries Circulation 74 1986 964 972
4. B. Christensen, H. Refsum, O. Vintermyr, and P.M. Ueland Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of nontransformed, transformed, proliferating and quiescent cells in culture J. Cell Biol. 146 1991 52 62
5. J. Selhub, P.F. Jacques, P.W. Wilson, D. Rush, and I.H. Rosenberg Vitamin status and intake as primary determinants of homocysteinemia in an elderly population JAMA 270 1993 2693 2698
6. S.-S. Kang, E.L. Passen, N. Ruggie, P.W. Wang, and H. Sora Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease Circulation 88 1993 1463 1469
7. I.M. Graham, L.E. Daly, H.M. Refsum, K. Robinson, L.E. Brattstrom, and P.M. Ueland Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project JAMA 277 1997 1775 1778
8. C.J. Boushey, S.A.A. Beresford, G.S. Omenn, and A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1056
9. K.S. Woo, P. Chook, and Y.I. Lolin Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Circulation 96 1997 2542 2544
10. A. Tawakol, T. Omland, M. Gerhard, J.T. Wu, and M.A. Creager Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans Circulation 95 1997 1119 1121
11. J.S. Stamler, J.A. Osborn, and O. Jaraji Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J. Clin. Invest. 91 1993 308 318
12. C.M. Gibson for the TIMI 4 Study Group TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
13. J.T. Dodge, B.G. Brown, E.L. Bolson, and H.T. Dodge Intrathoracic spatial location of specified coronary segments on the normal human heart: application in quantitative arteriography, assessment of regional risk and contraction, and anatomic display Circulation 78 1988 1167 1180
14. S.E. Epstein, O. Cannon, and T.L. Talbot Hemodynamic principles in the control of coronary blood flow Am. J. Cardiol. 56 1985 4E 10E
15. N. Kurtoglu, A. Akcay, and I. Dindar Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow Am. J. Cardiol. 87 2001 777 779
16. J.F. Beltrame, S.B. Limaye, R.D. Wuttke, and J.D. Horowitz Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon Am. Heart J. 146 2003 84 90
17. A. Camsari, H. Pekdemir, and D. Cicek Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow Circ. J. 67 2003 1022 1028
18. V.G. Cin, H. Pekdemir, and A. Camsari Diffuse intimal thickening of coronary arteries in slow coronary flow Jpn. Heart J. 44 2003 907 919
19. K. Senen, E. Yetkin, and H. Turhan Increased thrombolysis in myocardial infarction frame counts in patients with isolated coronary artery ectasia Heart Vessels 19 2004 23 26
20. J.C. Chambers, A. McGregor, J. Jean-Marie, and J.S. Kooner Acute hyperhomocysteinemia and endothelial dysfunction Lancet 351 1998 36 37
21. J. Constans, A.D. Blann, and F. Resplandy Endothelial dysfunction during acute methionine load in hyperhomocysteinemic patients Atherosclerosis 147 1999 411 413
22. A.T. Sezgin, A. Sigirci, and I. Barutcu Vascular endothelial function in patients with slow coronary flow Coron. Artery Dis. 14 2003 155 161
23. G. Starkebaum, and J.M. Harlan Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine J. Clin. Invest. 77 1986 1370 1376
24. G.N. Welch, G. Upchurch, and J. Loscalzo Hyperhomocysteinemia and atherothrombosis Ann. N. Y. Acad. Sci. U. S. A. 811 1997 48 58
25. G.R. Upchurch, G.N. Welch, and N. Ramdev The effect of homocysteine on endothelial cell nitric oxide production FASEB J. 9 1995 A876
26. G.R. Upchurch, G.N. Welch, J.F. Freedman, and J. Loscalzo Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury Circulation 92 1995 I-228
27. G.R. Upchurch, G.N. Welch, and A.J. Fabian Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase J. Biol. Chem. 272 1997 17012 17017
28. O. Stanger, H.J. Semmelrock, W. Wonisch, U. Bos, E. Pabst, and T.C. Wascher Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects J. Pharmacol. Exp. Ther. 303 2002 158 162
29. F.F. Willems, W.R. Aengevaeren, G.H. Boers, H.J. Blom, and F.W. Verheugt Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease J. Am. Coll. Cardiol. 40 2002 766 772
30. E.N. Arnett, J.M. Isner, and D.R. Redwood Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings Ann. Intern. Med. 91 1979 350 356
31. M.J. Chemarin-Alibelli, M.T. Pieraggi, and M. Elbaz Identification of coronary thrombus after myocardial infarction by intracoronary ultrasound compared with histology of tissues sampled by atherectomy Am. J. Cardiol. 77 1996 344 349
32. B.N. Potkin, A.L. Bartorelli, and J.M. Gessert Coronary artery imaging with intravascular high-frequency ultrasound Circulation 81 1990 1575 1585